Siriporn Toongsuwan

Title: Siriporn Toongsuwan: Innovator in Modified Release Formulations

Introduction

Siriporn Toongsuwan is a notable inventor based in Berlin, MA (US), recognized for her contributions to the field of pharmaceutical formulations. With a total of three patents to her name, she has made significant strides in the development of modified release compositions.

Latest Patents

Her latest patents focus on modified release formulations that utilize amisulpride in unique mixtures of its enantiomers. These compositions are designed in solid oral dosage forms, where the amount of (R)-amisulpride exceeds that of (S)-amisulpride. The medicaments developed from these formulations are aimed at treating various diseases and disorders, providing innovative methods for dosage regimens. Additionally, her work includes formulations that employ polymorphs of enantiomeric amisulpride, further enhancing the therapeutic potential of these compositions.

Career Highlights

Siriporn Toongsuwan is currently associated with Sunovion Pharmaceuticals Inc., where she continues to advance her research and development efforts. Her expertise in modified release formulations has positioned her as a key player in the pharmaceutical industry.

Collaborations

Throughout her career, she has collaborated with esteemed colleagues such as Takumi Asada and Gerald R Galluppi, contributing to a dynamic research environment that fosters innovation.

Conclusion

Siriporn Toongsuwan's work in modified release formulations exemplifies her commitment to improving therapeutic options for patients. Her innovative approaches and collaborations highlight her significant impact in the pharmaceutical field.